Xuejing Li
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IDeglira vs insulin degludec for type 2 diabetes: a systematic review and meta-analysis.
Journal: Frontiers in endocrinology
Published: June 08, 2025
Efficacy and safety of insulin efsitora in type 2 diabetes: a meta-analysis of randomized controlled trials.
Journal: Frontiers in endocrinology
Published: April 09, 2025
iGlarLixi for type 2 diabetes: a systematic review and meta-analysis.
Journal: Endocrine
Published: February 17, 2024
Knowledge, attitudes, and practice of physicians and pharmacists regarding the prevention and treatment of cardiovascular toxicity associated with cancer treatment.
Journal: Scientific reports
Published: November 17, 2023
IDegLira for type 2 diabetes: a systematic review and meta-analysis.
Journal: Endocrine
Published: June 19, 2023
The efficacy and safety of once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus: A systemic review and meta-analysis.
Journal: Medicine
Published: August 26, 2018
The safety and efficacy of once-weekly glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes mellitus: a systemic review and meta-analysis.
Journal: Endocrine
Published: April 19, 2018
Effects of triptolide on pharmacokinetics of fenofibrate in rats and its potential mechanism.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: February 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026